Ledger.Open graph →
SEC Form D · filed January 19, 2023

Thylacine Biotherapeutics Inc

Offering
$1.0M
Sold
$476K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MIAMI BEACH, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Robert Graifman · Miami Beach, FLDirectorTim Hysell · TUALATIN, ORDirectorDaniel Graifman · Miami Beach, FLExec · DirectorAndrew Fradkin · San Carlos, CADirectorMatthew J. Bernard · New York, NYDirectorDaniel Graifman · Miami Beach, FLExec · DirectorAndrew Fradkin · San Carlos, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗